L.A. County is paying off millions in medical debt — no strings attached. Do you qualify?
More than 134,000 Los Angeles County residents began getting notices in the mail Monday as part of the first wave of medical bill forgiveness made possible by the county's Medical Debt Relief Program. The first round of notices is expected to relieve more than $183 million in debt.
The program was launched, in partnership with the nonprofit Undue Medical Debt, in December 2024 with the mission of providing financial relief for eligible residents by purchasing and eliminating the debt. The funds for the program were made possible by an initial $5 million investment approved by the Los Angeles County Board of Supervisors with additional funds from L.A. Care Health Plan and the L.A. County Medical Assn.
The goal is to retire $500 million in medical debt for low-income residents, with plans to eliminate as much as $2 billion by seeking additional contributions from philanthropic partners, hospitals and health plans. That could mean the debt of millions of people would be wiped clean.
Through this program, the county provides the funding and Undue Medical Debt acquires qualifying debts in bulk for a fraction of their face value from provider partners such as hospitals and health systems along with collection agencies.
Far too many residents are "one medical bill away from fiscal catastrophe," said Holly Mitchell, Los Angeles County's 2nd District supervisor.
"In 2023 alone, Los Angeles County residents held over $2.9 billion in medical debt," Mitchell said.
Read more: Southern California cities top credit card debt list in new study
Recently analyzed data from 2023 found that 1 in 9 adults in the county are impacted by medical debt, and "many are low-income families who even with a lifetime of work may never escape it," said Janice Hahn, Los Angeles County's 4th District supervisor.
Adults with medical debt burdens are two to three times more likely to be food insecure, delay or forgo necessary medical care or prescriptions and experience housing instability than those without this burden, according to the data. Furthermore, the data say, about half of adults facing medical debt took on credit card debt to pay their medical bills.
"This kind of debt often gets bundled and sold to debt collectors pennies on the dollar who go mercilessly after the families and aggressively for the payment," Hahn said.
The relief program comes with no strings attached, so you don't have to pay taxes on it.
The "Undue" notification in the mail will list how much debt was forgiven and where the debt was owed, such as the hospital, clinic or collector that was trying to collect from you.
Since notices began hitting residences Monday, keep your eye out for the letters over the next few weeks.
Eligibility for the program is determined by income, family size and whether the healthcare provider that is owed the money has chosen to participate in the program.
To qualify for the program you must:
Be a resident of Los Angeles County.
Earn less or equal to 400% of the federal poverty level or have a medical bill that is 5% or more your annual household income. For example, in 2025, the income for a family of four that is 400% of the federal poverty level is $128,000.
Have eligible debt, which means you must have a bill from a hospital or clinic that is participating in the debt relief program, the bill is past due and you are not using a payment plan for the bill.
Read more: L.A. County approves $4-billion sex abuse settlement, largest in U.S. history
No. If you and your bill qualify for the program, Undue Medical Debt will pay off your debt and you will be notified through the mail.
Your bill qualifies for the program if the debt is held by hospitals, clinics or collectors that are participating in the program. The initial participating hospitals are Martin Luther King Jr. Community Hospital and Adventist Health White Memorial Hospital. County supervisors are calling on other debt holders to participate.
Relief cannot be requested.
If you received a letter from the county's Undue Medical Debt program, get in touch with the program online.
If you need help with medical bills, visit the county's Department of Public Health online list of resources for support. Potential resources include applying for free or discounted hospital services, legal advice and consumer counseling.
This program is not a scam: If the county has relieved your medical debt, you'll be notified by a letter in the mail from Los Angeles County and Undue Medical Debt. The envelope will have a county seal on it.
Keep the letter as part of your records that the medical debt has been forgiven.
Beware of alleged debt relief scammers that contact you via text, phone call or email. And don't fall for callers asking you to provide information or payment in exchange for medical debt relief.
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
This story originally appeared in Los Angeles Times.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 days ago
- CNBC
Healthy Returns: Researchers move closer to a universal cancer vaccine
A universal cancer vaccine – what once seemed like a pipe dream – may be inching closer to becoming reality. On Friday, University of Florida researchers said findings from a new study could lead to the development of a universal shot that can jumpstart the immune system to fight cancer. The study in mice, published in Nature Biomedical Engineering, showed that an experimental mRNA vaccine boosted the tumor-fighting effects of a common cancer drug called immune checkpoint inhibitors. The vaccine is not designed for a specific virus or cancer cells, but engineered to "wake up" the immune system against the disease, "spurring it to respond as if fighting a virus," according to a UF release. "What we found is by using a vaccine designed not to target cancer specifically but rather to stimulate a strong immunologic response, we could elicit a very strong anticancer reaction," Dr. Duane Mitchell, a co-author of the study and professor of neurosurgery at the university's College of Medicine, said in the release. That's unlike current approaches to cancer vaccines, which involve finding a target expressed by many cancer patients or, in the case of Moderna and Merck, developing personalized vaccines tailored to each patient's specific tumor. The universal vaccine has the potential to be used broadly across cancer patients, "even possibly leading us to an off-the-shelf cancer vaccine," Mitchell said. The UF researchers are still working to replicate the findings in humans. If they do, a one-size-fits-all vaccine could provide an alternative to surgery, radiation and chemotherapy. Here's how the vaccine works: The mRNA shot essentially tells the body to produce certain proteins that stimulate the immune system, including one called PD-L1, which is often found on the surface or inside of cancer cells. Those cells often use PD-L1 to hide from immune attacks. But by boosting PD-L1, the vaccine can actually make tumors more vulnerable to immune checkpoint inhibitors that block that protein, helping the immune system recognize and destroy the cancer. The study showed promising results on treatment-resistant tumors in skin cancers by combining the mRNA vaccine with a monoclonal antibody, a common immunotherapy drug that attempts to alert the immune system that a tumor is foreign and should be attacked. It also showed positive results when tested on mouse skin, bone and brain cancers as a solo treatment. In some cases, the tumors were eliminated entirely. "This paper describes a very unexpected and exciting observation: that even a vaccine not specific to any particular tumor or virus – so long as it is an mRNA vaccine – could lead to tumor-specific effects," said senior author Dr. Elias Sayour, a UF Health pediatric oncologist, in a release. Feel free to send any tips, suggestions, story ideas and data to Annika at We're just days away from the peak of digital health earnings season, and this quarter is sure to be an interesting one. The two companies that went public earlier this year, Hinge Health and Omada Health, will report results for the first time since their debut. And since President Donald Trump's tax-and-spending bill passed and his Aug. 1 tariff deadline is approaching, we'll get some insight into how digital health companies have been operating against a volatile macroeconomic and policy backdrop. Here are some of the reports CNBC will be watching for: Hinge Health – Aug. 5 Omada Health – Aug. 7 Hims & Hers Health – Aug. 4 Doximity – Aug. 7 Teladoc Health – July 29 We'll have plenty to dive into in the coming weeks, so be sure to keep up with CNBC's coverage. Feel free to send any tips, suggestions, story ideas and data to Ashley at
CBS News
3 days ago
- CBS News
Metro Detroiters struggling with medical debt hopeful for relief
Medical expenses, whether big or small, weigh on almost everyone. For many Michiganders, one bill can often lead to a spiral into serious debt. Carrecia Watkins knows that struggle firsthand after getting into a car accident back in 2023. "A big, huge impact that I wasn't ready for," Watkins said. "Someone hit me, and they were totally at fault, but because she didn't have any insurance, I was stuck with the bill." Still dealing with long-lasting injuries, Watkins now has close to $5,000 in medical bills and ongoing therapy costs for her recovery. "Now I've got this hefty medical bill that I have to pay, and there's nothing I can do," Watkins said. Watkins' story is one of thousands that pushed the Michigan Gov. Gretchen Whitmer's administration to announce a new partnership to address the growing problem. Working with the national nonprofit Undue Medical Debt, the plan takes on the medical bills at discounted rates and then forgives the charges. "This program just takes another burden off the table," said Dr. Kimberly Farrow, president and CEO of Central City Health, a community health center in downtown Detroit. Her team works directly with patients who may be uninsured or underinsured — many of whom would benefit directly from the new debt relief plan. "It's touching so many people on that spectrum, people who are severely impoverished and those who are like the working poor. They're working every day, but they just can't afford their medical bills," Farrow said. Under the current plan, nearly 210,000 Michiganders, including many who are patients at places like Central City Health, will get close to $144 million in medical debt completely erased. CBS News Detroit took a closer look and found that the program will help anyone who earns four times or less than the federal poverty level, or if their medical debts are equal to 5% or more of their annual income. "This program really provides relief for both the hospital systems that take care of our people, but also the patients that are struggling day to day to put food on the table," Farrow said. This first round clears outstanding bills for thousands of patients in many nearby Michigan counties, including Wayne, Macomb and St. Clair. People who qualify will start receiving information on their status in the coming months.
Yahoo
4 days ago
- Yahoo
Sarepta falls after gene therapy maker pauses Elevidys shipments in US
(Reuters) -Shares of Sarepta Therapeutics fell nearly 7% on Tuesday after the company agreed to comply with the U.S. health regulator's request to pause all shipments of its gene therapy Elevidys in the United States. The U.S. Food and Drug Administration on Friday asked Sarepta to voluntarily halt shipments of the gene therapy, but the company refused to do so and said it would continue making the treatment available to ambulatory patients. But Sarepta has now voluntarily and temporarily paused all shipments of the therapy, effective end of Tuesday. The company said the decision would allow it to respond to requests from the FDA and maintain a positive relationship with the agency. "Though Sarepta claims its pause in shipments was voluntary, we think the company moved preemptively — bracing for an inevitable FDA mandate to pull the drug," said H.C. Wainwright analyst Mitchell Kapoor. Shares of Sarepta fell 6.9% to $12.40 in early trading on Tuesday. "Sarepta's decision to comply was a capitulation after recognizing that the fight with the FDA was not winnable and that the agency would have strong-armed Sarepta into removing Elevidys with a formal demand," Kapoor added. Investor concerns regarding the use of the company's treatments have been heightened after the company on Friday disclosed that another patient who had received its experimental gene therapy died from acute liver failure, marking the third death this year. The company's shares have plummeted 89% so far this year. On Monday, Children's Hospital Los Angeles said it had paused usage of Elevidys in all patients with muscular dystrophy. The FDA's initial request had likely heightened the pressure on physicians to pause treatments, which could also have been a driving factor in Sarepta's decision, William Blair analyst Sami Corwin said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
